MSCs constitutively expressing and releasing nerve growth factor (NGF), a neuroprotective molecule controlling neurons’ survival and differentiation [36,37,38], could be used as therapeutics for the treatment of MS. This evidence concerns the gene NGF and myeloid sarcoma.